DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Isavuconazonium sulfateis the generic ingredient in one branded drug marketed by Astellas and is included in two NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Isavuconazonium sulfate has twenty-four patent family members in nineteen countries.
One supplier is listed for this compound.
Recent Clinical Trials for isavuconazonium sulfate
Identify potential brand extensions & 505(b)(2) entrants
|Astellas Pharma Global Development, Inc.||Phase 2|
|Asahi Kasei Pharma Corporation||Phase 3|
|Astellas Pharma US, Inc.||Phase 2|
Pharmacology for isavuconazonium sulfate
|Drug Class||Azole Antifungal |
|Mechanism of Action||Cytochrome P450 3A4 Inhibitors |
Organic Cation Transporter 2 Inhibitors
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Astellas||CRESEMBA||isavuconazonium sulfate||POWDER;INTRAVENOUS||207501-001||Mar 6, 2015||RX||Yes||Yes||Start Trial||Start Trial||Y||Start Trial|
|Astellas||CRESEMBA||isavuconazonium sulfate||CAPSULE;ORAL||207500-001||Mar 6, 2015||RX||Yes||Yes||Start Trial||Start Trial||Y||Start Trial|
|Astellas||CRESEMBA||isavuconazonium sulfate||POWDER;INTRAVENOUS||207501-001||Mar 6, 2015||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|1280795||2015/073||Ireland||Start Trial||PRODUCT NAME: ISAVUCONAZOLE AS ISAVUCONAZONIUM SULFATE OR AS ISAVUCONAZONIUM SALT WITH ANY OTHER PHARMACEUTICALLY ACCEPTABLE ANION, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE, OR SOLVATE; REGISTRATION NO/DATE: EU/1/15/1036 20151015|
|1280795||CA 2016 00002||Denmark||Start Trial||PRODUCT NAME: ISAVUCONAZOLE AS ISAVUCONAZONIUM SULFATE OR AS AN ISAVUCONAZONIUM SALT WITH ANY OTHER PHARMACEUTICALLY ACCEPTABLE ANION, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE, OR SOLVATE; REG. NO/DATE: EU/1/15/1036 20151019|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.